53. Which of the following situations would be appropriate for pharmacy staff to report to ISMP MERP?
Answer: A
A pharmacy dispenses methimazole instead of the intended metolazone
This situation is appropriate for pharmacy staff to report to ISMP MERP because it involves a medication error where one drug was dispensed in place of another, which could potentially harm the patient.
A) A pharmacy dispenses methimazole instead of the intended metolazone
This option is correct as it describes a clear case of a medication error. Dispensing methimazole instead of metolazone poses significant risks to the patient due to the lack of therapeutic benefit and the potential for adverse effects associated with the incorrect medication.
B) A patient experiences an unexpected side effect after taking a new medication
While unexpected side effects should be monitored and reported, this situation does not directly indicate a medication error but rather an adverse drug reaction. Reporting to ISMP MERP is specifically intended for medication errors rather than side effects.
C) A patient experiences therapeutic failure after switching generic manufacturers
This scenario relates to therapeutic outcomes but does not indicate that a medication error occurred. The issue of therapeutic failure due to a switch in manufacturers does not fit the definition of an error that should be reported to ISMP MERP.
D) A pharmacy technician suspects that a medication might be counterfeit
Although the suspicion of counterfeit medications is serious and should be investigated, it does not reflect an actual medication error in dispensing or administration. Reporting counterfeit medications may fall under different regulatory or safety reporting systems rather than ISMP MERP.
Conclusion
The selection of option A is definitive as it represents a direct medication error that could significantly impact patient safety. In contrast, the other options do not involve errors in dispensing or administration that are the primary focus of reports to ISMP MERP. Therefore, option A stands out as the only appropriate scenario for reporting within the context of medication safety.